-

 

Rheumatic Heart Disease and PFAS: Mechanisms, Progression, and Impacts on Child Growth and Development

Abstract

Rheumatic heart disease (RHD) remains one of the most persistent cardiovascular diseases of poverty, disproportionately affecting children and young adults in low- and middle-income countries (LMICs). Traditionally regarded as a sequela of untreated Group A Streptococcus infections, RHD is now recognized as a multifactorial condition shaped by environmental, immunological, and socioeconomic factors. Among these, exposure to per- and polyfluoroalkyl substances (PFAS)—a class of persistent synthetic chemicals—represents an emerging and underappreciated threat. PFAS compounds, widely distributed in the environment, possess immune-modulating, endocrine-disrupting, and pro-inflammatory properties that can exacerbate autoimmune and fibrotic processes central to RHD. This paper explores the molecular and developmental intersections between PFAS exposure and RHD, emphasizing implications for child health, growth, and global health equity.

1. Introduction

Rheumatic heart disease (RHD) continues to cause over 300,000 premature deaths annually (WHO, 2023). Although global incidence has declined in high-income nations, endemic transmission persists across sub-Saharan Africa, South Asia, Oceania, and Latin America, reflecting inequities in healthcare access, environmental safety, and poverty reduction.

Simultaneously, the world faces a rising tide of chemical pollution, led by PFAS—manufactured substances used in food packaging, textiles, non-stick cookware, firefighting foams, and industrial coatings. PFAS are now detected in air, water, soil, and human blood worldwide, including in regions with no direct production, due to atmospheric and hydrological transport. Children and young adults in informal settlements, mining regions, or near e-waste dumpsites are particularly vulnerable.

The convergence of infectious and chemical exposures is reshaping the epidemiology of cardiovascular disease in developing regions. Chronic PFAS exposure can potentiate immune dysregulation and inflammation, aggravating the autoimmunity underlying RHD. This nexus demands urgent interdisciplinary attention linking environmental toxicology, cardiology, and developmental health.

2. PFAS Exposure Pathways and Global Burden

2.1 The Ubiquity of PFAS

PFAS comprise over 12,000 compounds with strong carbon–fluorine bonds, rendering them resistant to natural degradation. They bioaccumulate in human tissue and have half-lives of 2–9 years in serum. Major PFAS forms—PFOS, PFOA, PFHxS, and GenX—are classified as persistent organic pollutants (POPs).

2.2 Exposure Pathways

  1. Drinking Water Contamination: PFAS infiltrate aquifers near manufacturing or waste sites.

  2. Food Chains: Bioaccumulation in fish, meat, and crops irrigated with contaminated water.

  3. Consumer Products: PFAS in carpets, clothing, food packaging, and cookware contribute to household exposure.

  4. Maternal–Child Transmission: PFAS cross the placenta and are secreted in breast milk, exposing fetuses and infants during critical developmental stages.

2.3 Global Burden

A 2024 UNEP report estimates that 99 percent of the world’s population has detectable PFAS in their blood. Africa’s urban poor are increasingly at risk due to informal recycling of electronics and unregulated imports of PFAS-containing goods. Communities in Kenya, Ghana, and South Africa report PFAS concentrations in water exceeding WHO guidelines, overlapping geographically with RHD-endemic zones.

3. Mechanistic Pathways: How PFAS Interacts with RHD Biology

3.1 Immune Modulation and Autoimmunity

RHD arises from autoimmune cross-reactivity following Streptococcus pyogenes infection. PFAS alter immune balance by suppressing regulatory T cells and hyperactivating Th17 cells, amplifying cytokine storms and promoting molecular mimicry. Chronic exposure enhances autoantibody production against cardiac myosin, tropomyosin, and laminin, driving progressive valvular inflammation.

3.2 Oxidative Stress and Endothelial Injury

PFAS induce reactive oxygen species (ROS) generation and impair endothelial nitric oxide synthase activity, leading to microvascular dysfunction. In RHD-prone individuals, this endothelial stress accelerates fibrosis, calcification, and valvular stenosis, hallmark features of chronic RHD.

3.3 Hormonal and Metabolic Interference

PFAS interfere with thyroid, estrogen, and lipid metabolism, hormones vital for cardiac growth and energy homeostasis. Children with altered thyroid function exhibit reduced myocardial contractility and delayed physical growth, compounding the clinical burden of RHD.

3.4 Epigenetic Reprogramming

Early-life PFAS exposure modifies DNA methylation of immune and cardiac genes (e.g., IL6, TGF-β, MYH7), predisposing individuals to persistent inflammation and reduced regenerative capacity. These epigenetic “scars” may transmit across generations, extending vulnerability to RHD and other inflammatory heart diseases.

4. Developmental and Health Implications for Children and Young Adults

4.1 Cardiovascular and Pulmonary Outcomes

Children exposed to PFAS and living with RHD experience compounded cardiopulmonary stress. PFAS-induced microvascular damage and lipid dysregulation worsen myocardial remodeling, while decreased oxygenation from valvular dysfunction impairs brain and muscle development.

4.2 Growth Retardation and Nutritional Deficits

RHD limits energy efficiency, and PFAS disrupt endocrine regulation of metabolism and bone growth. Combined, they cause stunting, reduced muscle mass, and delayed puberty, especially in malnourished populations.

4.3 Neurodevelopmental Effects

PFAS cross the blood–brain barrier, affecting myelination, neurotransmitter signaling, and neuroinflammation. Children with RHD-related hypoxia face added cognitive delays and poor academic performance, creating a cycle of biological and social disadvantage.

4.4 Psychosocial and Gender Dimensions

Girls and young women face dual burdens—disproportionate caregiving responsibilities and reproductive risks from PFAS. PFAS exposure in pregnancy increases the likelihood of low birth weight, congenital cardiac anomalies, and later-life cardiovascular vulnerability in offspring.

5. Global Epidemiological Trends

  • Sub-Saharan Africa and South Asia bear 80% of RHD cases and increasing PFAS exposure from imported consumer goods and e-waste.

  • In industrialized countries, PFAS exposure correlates with autoimmune myocarditis and early-onset hypertension, supporting a mechanistic continuum.

  • The Global Burden of Disease (2024) attributes roughly 12% of new childhood cardiac dysfunctions to environmental chemical exposures, including PFAS.

  • Climate change amplifies PFAS mobility in surface waters and groundwater, potentially expanding exposure zones in flood-prone African and Asian regions.

6. The Policy–Research Gap

Current RHD interventions—penicillin prophylaxis, surgery, and infection control—rarely address environmental factors. Likewise, chemical safety frameworks seldom consider cardiovascular outcomes. Bridging these silos is essential for global child health equity.

7. Policy and Strategic Framework for Action

Policy DomainStrategic ActionKey Actors
Environmental GovernanceEnforce PFAS phase-out under the Stockholm Convention and monitor in water and food systemsUNEP, FAO, National EPAs
Health SurveillanceIntegrate PFAS biomarkers and cardiac health metrics into WHO child health registriesWHO, UNICEF, National Health Ministries
Integrated Child Health ProgramsScreen schoolchildren for RHD and environmental exposures simultaneouslyMinistries of Education and Health
Research & InnovationFund African and Asian studies on PFAS–RHD interactionsGlobal Fund, NIH, African Academy of Sciences
Public Health EducationRaise awareness on chemical hygiene, safe waste disposal, and infection preventionNGOs, Community Health Workers
Circular Economy TransitionsPromote PFAS-free manufacturing and responsible e-waste recyclingPrivate Sector Coalitions, UNIDO

8. A Planetary Health Perspective

The intersection of PFAS contamination and RHD reflects a planetary health paradox—where industrial and technological advances inadvertently perpetuate disease among the world’s poorest children. PFAS represent a form of chemical colonialism, where pollutants produced in industrialized economies migrate to developing nations through trade, waste, and water systems.

Addressing this requires moving beyond biomedical interventions toward systemic environmental reform—integrating cardiovascular prevention with climate resilience, water governance, and chemical safety policies.

9. Conclusion

Rheumatic heart disease in the 21st century is no longer just an infectious disease—it is an ecological manifestation of inequity, pollution, and underdevelopment. PFAS amplify RHD through immune dysregulation, oxidative stress, and endocrine disruption, undermining child growth, cardiac health, and cognitive potential.

Protecting children from this dual burden demands multilevel cooperation—from local community interventions and clean water initiatives to global regulatory reform of persistent chemicals. Safeguarding child cardiovascular health is both a moral imperative and a benchmark for sustainable development in the post-2030 global health agenda.

Key References

  1. WHO (2023). Global Report on Rheumatic Heart Disease and Child Health.

  2. UNEP (2024). Global Chemicals Outlook III.

  3. Grandjean, P. & Clapp, R. (2022). PFAS Exposure and Immune-Mediated Disease. Environmental Health Perspectives.

  4. Watkins, D. A. et al. (2020). Global Epidemiology of Rheumatic Heart Disease. Lancet Global Health.

  5. Sunderland, E. M. et al. (2021). Transboundary PFAS Pollution and Cardiovascular Risk. Science of the Total Environment.

  6. Engel, S. M. et al. (2021). Endocrine Disruption and Child Growth Impairment from PFAS. Environmental Research.

  7. Björnsdotter, M. K. et al. (2023). Prenatal PFAS Exposure and Cardiac Development. Environmental International.

  8. WHO–UNICEF (2024). Integrating Environmental and Cardiovascular Health in Child Programs.

Comments

Post a Comment

Popular posts from this blog

-
  Impacts of Pit Latrine Waste on Early Puberty in Africa Introduction Across sub-Saharan Africa, pit latrines serve as the primary sanitation infrastructure for over 50% of urban populations and an even higher proportion in rural areas, providing a low-cost solution to the challenge of open defecation. These simple, often unlined pits collect human waste but pose significant risks to environmental and public health due to potential groundwater contamination. Emerging evidence suggests that chemical pollutants from pit latrines, particularly endocrine-disrupting chemicals (EDCs), may contribute to early puberty in children, especially girls, with far-reaching health, social, and educational consequences. Early puberty, defined as pubertal development before age 8 in girls or 9 in boys, is associated with increased risks of mental health disorders, reproductive health issues, and socioeconomic challenges, particularly in resource-constrained settings. In Africa, where sanitation inf...
Read more
-
  Health insurance affordability and the quality of life among low Socioeconomic Status (SES) individuals in Low- and Middle-Income Countries (LMICs)   Preamble: Whereas the right to health is a fundamental human right, it remains inaccessible to many, especially those of low socioeconomic status (SES) in low- and middle-income countries (LMICs); and whereas the affordability of health insurance is a critical factor that can enhance or impede access to necessary healthcare services; we recognize that the ability to obtain health insurance plays a pivotal role in determining the quality of life for individuals and families within these communities. Acknowledging that the lack of affordable health insurance options leads to a disproportionate burden of disease and financial hardship on low SES populations; and understanding that the provision of affordable health insurance is not only a matter of social justice but also an investment in the social and economic development ...
Read more
-
Child Health:  Dealing with Aflatoxins in Children’s Food Aflatoxins, produced primarily by Aspergillus flavus and A. parasiticus , are highly toxic and carcinogenic mycotoxins that contaminate key food crops in tropical and subtropical regions. In low- and middle-income countries (LMICs), especially across sub-Saharan Africa, chronic exposure to aflatoxins in staple foods poses grave health risks for children, including growth impairment, immunosuppression, developmental deficits, and increased vulnerability to infectious diseases. This paper explores the sources of aflatoxin contamination in children's food, its public health impacts, and proposes multisectoral policies and interventions to protect child health and nutrition, with a focus on evidence from Africa. 1. Introduction Aflatoxin contamination is one of the most pressing yet under-addressed food safety challenges affecting children in LMICs. Staple foods such as maize, sorghum, groundnuts, and dairy products are pro...
Read more